13G Filing: Sabby Capital and Genetic Technologies Limited (ADR) (GENE)

Page 3 of 7 – SEC Filing

6.
SHARED VOTING POWER 07.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 09.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 010.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)012.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO
CUSIP No.
37185R2081.
NAME OF REPORTING PERSONSHal Mintz2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONUSANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 07.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 09.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 010.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)012.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN?

CUSIP No.
37185R208

Item 1.
(a).
Name of Issuer:

Follow Genetic Technologies Ltd (NASDAQ:GENE)